Market Overview

UPDATE: Jefferies Raises PT on Accuray Following Good F4Q Results

Related ARAY
A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month
Morning Market Gainers

In a report published Wednesday, Jefferies analyst Raj Denhoy reiterated a Buy rating on Accuray (NASDAQ: ARAY), and raised the price target from $6.50 to $8.00.

In the report, Jefferies noted, “ARAY posted a good F4Q with a modest revenue beat, tighter expense controls, and another sequential uptick in bookings. Initial F14 guidance calls for continued order momentum albeit with a slightly higher opex run-rate. The continued bookings resurgence coupled with cost controls make the still distressed valuation increasingly unsustainable. We stay at Buy and PT goes to $8.”

Accuray closed on Tuesday at $6.10.

Latest Ratings for ARAY

Nov 2015CitigroupInitiates Coverage onSell
Jan 2015Northland SecuritiesInitiates Coverage onOutperform
Jun 2014JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for ARAY
View the Latest Analyst Ratings

Posted-In: Jefferies Raj DenhoyAnalyst Color Price Target Analyst Ratings


Related Articles (ARAY)

Get Benzinga's Newsletters